DIA Europe 2019 has ended
Back To Schedule
Wednesday, February 6 • 15:15 - 16:15
#S0603: Value Assessment of Combinations in Oncology (or others): Questions and Steps toward Practical Solutions

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

Component Type: Session

The panel will discuss likely solutions for allowing patients to get access to combination drugs in oncology in a fast and sustainable manner. Panellists will also describe positive developments and highlight what they see as practical ways to advance the debate on this critical matter for the treatment of oncology.


Meni Styliadou


Francis Arickx

Fiona Carlin

Michael Schroter, PhD, MBA

Timothy Wilsdon, MS

avatar for Francis Arickx

Francis Arickx

Head of the Directorate Pharmaceutical Policy, National Institute for Health and Disability Insurance (RIZIV-INAMI)
Francis Arickx is head of the directorate Reimbursement of Medicines and Pharmaceutical Policy within the Health Care Department at the National Institute for Health and Disability Insurance (NIHDI RIZIV/INAMI) in Belgium. He manages administrative and scientific assessments, and... Read More →

Fiona Carlin

Partner, Baker McKenzie

Michael Schroter

Founding Partner, Viopas
Michael is a managing partner at Viopas, a venture capital and asset management firm investing in privately held and listed companies with a sustainable healthcare focus. As such Viopas favours investments in solutions which deliver cost-effective and improved clinical outcomes. Prior... Read More →

Meni Styliadou

VP Government Affairs & Public Policy, Europe & Canada, Takeda

Timothy Wilsdon

Principal, Charles River Associates International

Wednesday February 6, 2019 15:15 - 16:15 CET
K1 Austria Center Vienna Bruno-Kreisky-Platz 1 1220 Vienna Austria
  06 Access to Medicines, Session
  • Featured Topics Value and Access
  • Tags Session